Research study Program year 2022 Source: CMS Open Payments

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled,

Research payments

$3,203,555

485 payments

Through program year 2022, $3,203,555 in research payments was reported against A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled,, across 485 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$442,742	76
2021	Research	$296,351	132
2020	Research	$586,860	128
2019	Research	$1,877,602	149

Breakdown

Who paid Research payments · program years 2019–2022

GlaxoSmithKline, LLC. $3,203,555 485 payments

Who received the money Research payments · program years 2019–2022

June DO Pc Organisation paid for research $278,304 16 payments
Arthritis Northwest Pllc Organisation paid for research $211,183 15 payments
Southcoast Research Center INC Organisation paid for research $201,372 22 payments
The Regents Of The University Of Michigan Organisation paid for research $184,339 59 payments
Baycare Medical Group Organisation paid for research $168,499 28 payments
Baycare Medical Group INC Organisation paid for research $165,422 7 payments
Aards Research INC Organisation paid for research $140,726 13 payments
University Of Alabama At Birmingham Organisation paid for research $129,727 6 payments
Austin Regional Clinic Organisation paid for research $115,336 9 payments
East Bay Rheumatology Medical Organisation paid for research $98,569 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.